content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Press Coverage

content_middle

Scimitar Equity’s Regenerative Medicine Investors New Website Delivers Actionable Intelligence

 

Wayland, MA  July 13, 2013 -- Scimitar’s Regenerative Medicine Investors (RMi)  launched a new website that provides investors with information needed to validate share appreciation in the evolving stem, cell therapy and regenerative medicine (RegMed) sector.